Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Different brain tumors have the same origin, new findings show

  • Heavy drinking in adolescence associated with lasting brain changes, animal study suggests

  • Brain abnormalities found in chronic fatigue patients

  • Nano ruffles in brain matter

  • EEG test to help understand, treat schizophrenia

  • PET scans reveal how psychodynamic therapy for depression may change brain function

  • Suicide resilience, vulnerability among African-American adults focus of new research

  • Preventative action prior to brain surgery: Ultra-high-field MRI reveals language centers in brain in much more detail

  • Does having children make us any happier?

  • Self-reported sleep disturbances linked to higher risk for Alzheimer's disease in men

  •